Company: BOF
Filing Date: 2025-11-14
Form Type: DEF 14A
Source: 0001493152-25-023449
Chunk: 16

Company: BranchOut Food Inc.
Filing Date: 2025-11-14
Form: DEF 14A
Chunk 16
---
 director, executive officer, or beneficial owner of more than 10% of our common stock that failed to file on a timely basis reports required by Section 16(a) of the Exchange Act during the most recent fiscal year, except for one late filing of a Form 4 by each of Eric Healy, John Dalfonsi, Byron Riché Jones, Greg Somerville, Daniel Kaufman and Kaufman Kapital LLC, and a Form 3 filed late by Daniel Kaufman and Kaufman Kapital LLC.

<div align='center'>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</div>

Other than the transactions described below, there has not been, nor is there currently proposed, any transaction or series of similar transactions to which we were or will be a party:

| ● | in                                                                                                                                  
 which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last 
 two completed fiscal years; and                                                                                                     |
| ● | in                                                                                                                                  
 which any director, executive officer, stockholders who beneficially owns more than 5% of our common stock or any member of their   
 immediate family had or will have a direct or indirect material interest.                                                           |

Convertible Notes Payable

On July 15, 2024, the Company entered into a Securities Purchase Agreement (as amended, the “SPA”) with Daniel L. Kaufman, pursuant to which Mr. Kaufman agreed to purchase from the Company, in a private placement (i) a 12% Senior Secured Convertible Promissory Note in the principal amount of up to $3,400,000 (the “Convertible Note”), convertible into shares of the Company’s common stock at a fixed price of $0.7582 per share of common stock, a (ii) a warrant to purchase 1,000,000 shares of common stock at an exercise price of $1.00 per share (the “$1.00 Warrant”), and (iii) a warrant to purchase 500,000 shares of common stock at an exercise price of $1.50 per share (the “$1.50 Warrant” and, together with the $1.00 Warrant, the “Warrants” and together with the Convertible Note, the “Purchased Securities”), in consideration of an initial loan in the principal amount of $2,000,000 (the “Initial Loan”) made to the Company under the Convertible Note, subject to the terms